All News about Bristol-Myers Squibb
![](https://mms.businesswire.com/media/20240405022982/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://investorplace.com/wp-content/uploads/2020/09/biotech-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/BristolMeyersSquibb-Courtesyof-02-LVL-Ex_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/771419/investor-stock-charts-screens-getty.jpg)
![](https://g.foolcdn.com/editorial/images/770562/physician-giving-medicine-to-elderly-patient.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Check Out What Whales Are Doing With BMY
March 19, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240403030392/en/2088816/22/ABECMA_Logo.jpg)
![](https://mms.businesswire.com/media/20240402231542/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://investorplace.com/wp-content/uploads/2023/01/hotstocks1600-1024x576.png)
![](https://mms.businesswire.com/media/20240402638203/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/pharma-lab-worker-ai_18.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20240328963924/en/2041631/5/bms_logo_300_rgb_pos.jpg)
From Bristol Myers Squibb
Via Business Wire
![](https://mms.businesswire.com/media/20240327817166/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks With Whale Alerts In Today's Session
March 28, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2024/03/TECHpic-brain-040124-shutt.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/MerckCo_5.png?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20240322756721/en/2041631/5/bms_logo_300_rgb_pos.jpg)
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
March 26, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20240322953592/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/Bristol-Myers-Squibb--Moreton--Wirral---_1.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240320035615/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://cdn.benzinga.com/files/genscript_1.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240319007104/en/2041631/5/bms_logo_300_rgb_pos.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240319192215_geron-stock-doubles-after-imetelstat-receives-fda.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/AstraZeneca-HQ-in-Cambridge-UK_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.